CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Operating expenses:
Cost of goods sold	$ 1,256
Research and development	103,738	$ 125,046	$ 95,518
Selling, general and administrative	145,732	69,135	43,628
Total operating expenses	250,726	194,181	139,146
Loss from operations	(173,732)	(193,944)	(138,550)
Interest income	19,607	18,152	2,529
Interest expense	(18,504)	(8,312)	(6,882)
Other income (expense), net	(236)	(23)	1,002
Loss on extinguishment of debt	(1,707)
Net loss	$ (174,572)	$ (184,127)	$ (141,901)
Basic net loss per share	$ (0.27)	$ (0.32)	$ (0.37)
Diluted net loss per share	$ (0.27)	$ (0.32)	$ (0.37)
Shares used in computing basic net loss per share	646,033,247	570,645,405	380,784,846
Shares used in computing diluted net loss per share	646,033,247	570,645,405	380,784,846
Product Revenue, Net
Revenues:
Revenues:	$ 76,495	$ 0	$ 0
License Fees and Royalties
Revenues:
Revenues:	$ 499	$ 237	$ 596

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.